Correction: Synthetic tetracycline-controllable shRNA targeting long non-coding RNA HOXD-AS1 inhibits the progression of bladder cancer

Jianfa Li; Chengle Zhuang; Yuchen Liu; Mingwei Chen; Yincong Chen; Zhicong Chen; Anbang He; Junhao Lin; Yonghao Zhan; Li Liu; Wen Xu; Guoping Zhao; Yinglu Guo; Hanwei Wu; Zhiming Cai; Weiren Huang

doi:10.1186/s13046-023-02908-6

Correction: Synthetic tetracycline-controllable shRNA targeting long non-coding RNA HOXD-AS1 inhibits the progression of bladder cancer

J Exp Clin Cancer Res. 2023 Nov 28;42(1):321. doi: 10.1186/s13046-023-02908-6.

Authors

Jianfa Li^#^{1

2}, Chengle Zhuang^#^{1

2

3}, Yuchen Liu^#¹, Mingwei Chen^#^{1

4}, Yincong Chen², Zhicong Chen^{1

2}, Anbang He^{1

4}, Junhao Lin^{1

2}, Yonghao Zhan^{1

2}, Li Liu^{1

2}, Wen Xu¹, Guoping Zhao⁵, Yinglu Guo⁶, Hanwei Wu¹, Zhiming Cai^{7

8

9

10}, Weiren Huang^{11

12

13

14}

Affiliations

¹ Guangdong Province, Key Laboratory of Medical Reprogramming Technology, Shenzhen Second People's Hospital, Clinical Institute of Shantou University Medical College, First Affiliated Hospital of Shenzhen University, Shenzhen, 518039, People's Republic of China.
² Guangdong Province, Shantou University Medical College, Shantou, 515041, People's Republic of China.
³ Guangdong and Shenzhen Key Laboratory of Male Reproductive Medicine and Genetics, Institute of Urology, Peking University Shenzhen, Hospital, Shenzhen PKU-HKUST Medical Center, Shenzhen, 518036, People's Republic of China.
⁴ Anhui Province People's, Anhui Medical University, Hefei, 230000, Republic of China.
⁵ Shanghai-MOST Key Laboratory of Health and Disease Genomics, Chinese National Human Genome Center at Shanghai, Shanghai, 200000, People's Republic of China.
⁶ Department of Urology, Peking University First Hospital, Institute of Urology, Peking University, National Urological Cancer Center, Beijing, 100034, People's Republic of China.
⁷ Guangdong Province, Key Laboratory of Medical Reprogramming Technology, Shenzhen Second People's Hospital, Clinical Institute of Shantou University Medical College, First Affiliated Hospital of Shenzhen University, Shenzhen, 518039, People's Republic of China. caizhiming@yahoo.com.cn.
⁸ Guangdong Province, Shantou University Medical College, Shantou, 515041, People's Republic of China. caizhiming@yahoo.com.cn.
⁹ Anhui Province People's, Anhui Medical University, Hefei, 230000, Republic of China. caizhiming@yahoo.com.cn.
¹⁰ Department of Urology, Peking University First Hospital, Institute of Urology, Peking University, National Urological Cancer Center, Beijing, 100034, People's Republic of China. caizhiming@yahoo.com.cn.
¹¹ Guangdong Province, Key Laboratory of Medical Reprogramming Technology, Shenzhen Second People's Hospital, Clinical Institute of Shantou University Medical College, First Affiliated Hospital of Shenzhen University, Shenzhen, 518039, People's Republic of China. pony8980@163.com.
¹² Guangdong Province, Shantou University Medical College, Shantou, 515041, People's Republic of China. pony8980@163.com.
¹³ Anhui Province People's, Anhui Medical University, Hefei, 230000, Republic of China. pony8980@163.com.
¹⁴ Department of Urology, Peking University First Hospital, Institute of Urology, Peking University, National Urological Cancer Center, Beijing, 100034, People's Republic of China. pony8980@163.com.

^# Contributed equally.

No abstract available

Publication types

Published Erratum